A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients

Clinical trial NCT04938180 · TERMINATED

Trial details

NCT number: NCT04938180
Sponsor: AmMax Bio, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Tenosynovial Giant Cell Tumor Pigmented Villonodular Synovitis TGCT PVNS - Pigmented Villonodular Synovitis

Start date: 2021-09-16
Primary completion: 2022-04-20
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.